找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomedical Translational Research; Drug Design and Disc R.C. Sobti,Naranjan S. Dhalla Book 2022 The Editor(s) (if applicable) and The Autho

[復(fù)制鏈接]
樓主: ambulance
41#
發(fā)表于 2025-3-28 18:40:01 | 只看該作者
42#
發(fā)表于 2025-3-28 20:26:31 | 只看該作者
David H Duncan,Brendan A Wintleudy polypharmacology in the drug development process. Polypharmacology has emerged as a new paradigm in drug discovery as it promises to provide novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.
43#
發(fā)表于 2025-3-29 01:24:36 | 只看該作者
Polypharmacology: New Paradigms in Drug Developmentudy polypharmacology in the drug development process. Polypharmacology has emerged as a new paradigm in drug discovery as it promises to provide novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.
44#
發(fā)表于 2025-3-29 03:16:16 | 只看該作者
Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatmentt the polymerization of tubulins; thus, naftopidil may exhibit general cytotoxicity in many types of cells. Recent evidence has supported that additive naftopidil treatment in combination with chemotherapy could be a new clinical application for the treatment of prostate cancer.
45#
發(fā)表于 2025-3-29 10:59:58 | 只看該作者
tional approach.Provides a brief overview of microdosing for.This book, which is the third volume of Biomedical translational research, focuses on the fundamental role of biomedical research in developing new medicinal products. It emphasizes the importance of understanding biological and pathophysi
46#
發(fā)表于 2025-3-29 13:37:53 | 只看該作者
David H Duncan,Brendan A Wintle existing experimental, approved, discontinued, or shelved drugs for several diseases. This article provides a brief synopsis about repurposing and particularly evokes its most recent scientific basis used to render it more efficient.
47#
發(fā)表于 2025-3-29 16:34:06 | 只看該作者
Drug Repurposing in Biomedical Research: Benefits and Challenges existing experimental, approved, discontinued, or shelved drugs for several diseases. This article provides a brief synopsis about repurposing and particularly evokes its most recent scientific basis used to render it more efficient.
48#
發(fā)表于 2025-3-29 23:17:30 | 只看該作者
49#
發(fā)表于 2025-3-30 02:22:09 | 只看該作者
Nanotechnology in Dentistryts for early diagnosis and prompt treatment of oral cancer has the potential to redefine the dental practice enormously. Future research needs to be focussed on addressing the production and social and biological challenges for adopting nanodentistry in clinical practice.
50#
發(fā)表于 2025-3-30 05:42:57 | 只看該作者
Emerging Technologies: Gateway to Understand Molecular Insight of Diseases, Newer Drugs, Their Desigl methods. New data can be converted into usable knowledge to allow for faster diagnosis and treatment choices using these advanced technologies, such as artificial intelligence, machine learning algorithms, computational biology, and digital BMs. As a result, it is expected that such advancements w
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 00:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
河津市| 武隆县| 武功县| 正宁县| 新乡县| 盐山县| 郸城县| 新宁县| 封丘县| 申扎县| 平遥县| 荔波县| 绿春县| 冷水江市| 武冈市| 清丰县| 闽清县| 宜春市| 松阳县| 龙胜| 华蓥市| 新乡县| 正安县| 新乡市| 米易县| 昌图县| 昌宁县| 林口县| 渝中区| 汨罗市| 巴青县| 临猗县| 锡林郭勒盟| 章丘市| 贵德县| 虎林市| 泸水县| 德清县| 巴东县| 察雅县| 壶关县|